News

Hyderabad-based Natco Pharma has filed a lawsuit against Danish drugmaker Novo Nordisk, the maker of blockbuster weight-loss drug Wegovy (semaglutide), before the Delhi High Court.
With promising new obesity treatments in the pipeline, 24/7 Wall St. projects huge upside for Novo Nordisk stock through 2030 ...
Ascendis Pharma's TransCon platform shows promise, but challenges with rollout, competition, and execution risks lead to a Hold rating.
Novo Nordisk, the Denmark-based pharmaceutical company that makes Ozempic and Wegovy, looks like it's being toppled ... Novo ...
Wegovy is now the second medicine approved in the U.S. for a disease that affects millions. Novo Nordisk has several other factors working in its favor, including strong results and a solid pipeline.
Many Mounjaro users have considered making the swap after Eli Lilly announced prices would be increasing in the UK by 170 ...
Families of children at Camp Mystic who died in the devastating floods in Texas last month made emotional testimonies and ...
A steep decline in Ozempic maker Novo Nordisk’s share price has sent consumer confidence in Denmark to a three-month low.
I’ve seen what happens to people who use counterfeit skinny jabs – as unwittingly happened to the reality star Aisleyne Horgan-Wallace – and ‘Fauxzempic’ is a gateway to a world of painful side ...
European stocks fell Thursday as investors weighed ongoing concerns about the artificial-intelligence boom and data showing gains in business activity. The composite purchasing managers' index for the ...
Aisleyne Horgan-Wallace, a former Big Brother star, had such an adverse reaction to a suspected fake weight-loss jab she ...
Patients' vision loss, which is rare according to a new study, is also the subject of multiple lawsuits, including two filed ...